Josh Johnston, OD, FAAO, evaluates the nuances integral to success with new technology for premium cataract surgery. He is the clinical and residency director at Georgia Eye Partners in Atlanta. Johnston reports he is a consultant to Alcon, Allergan, Bio-Tissue, Johnson & Johnson Vision and Shire.

BLOG: Retina pathology to consider before cataract surgery

September 20, 2018

Understanding any structural abnormalities or pathology prior to cataract surgery is imperative. Not all pathology is a contraindication to surgery, but it is critical…

BLOG: Cataract surgery in short and long eyes

August 20, 2018

Small eyes and big ones have special considerations. Cataract surgery in either very short or very long eyes presents specific, unique situations. Challenges in short…

BLOG: IOL formulas and effective lens position

July 19, 2018

Choosing the correct IOL power is key to a successful cataract surgery. This power is based on the eye’s anatomical and optical measurements. One of the most…

BLOG: Toward fewer bad surprises

June 15, 2018

A refractive surprise after cataract surgery is a dreaded outcome for the surgeon and, more importantly, a satisfaction killer for patients. No matter what type of…

BLOG: Astigmatism correction essential to 20/happy cataract outcomes

May 14, 2018

We know that today’s cataract surgery is truly refractive cataract surgery. As such, patients expect refractive type outcomes after the procedure. Therefore, more…

BLOG: Why ODs should comanage cataract surgery

April 12, 2018

The sheer numbers provide much of the obvious evidence of why optometrists need to be involved in the comanagement of cataract surgery. Currently, about 3 million…